By Lisa Nainggolan
June 6, 2022 — A drug recently approved for type 2 diabetes in the United States is also very effective for treating obesity and has shown better weight loss than any previous medication, according to results from a new clinical trial. In the new study — which focused on patients with obesity but without diabetes — more than 90% of patients taking the highest dosage of tirzepatide lost of at least 5% of their weight, says endocrinologist Ania M. Jastreboff, MD, the doctor who led the study. Read more HERE.
FYI: insurance companies don’t seem willing to pay for it as a weight-loss drug but may be willing to pay for it to treat diabetes.
Total Page Visits: 719 - Today Page Visits: 2